Rajthanee Hospital Valuation

Q: What is the Fair Price of RJH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

RJH-R (THB22.6) is trading above our estimate of [[fair value]] (THB3.94)

Is RJH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RJH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RJH-R (THB22.6) is trading above our estimate of fair value (THB3.94)

Significantly Below Fair Value: RJH-R is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RJH-R?

Key metric: As RJH-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for RJH-R. This is calculated by dividing RJH-R's market cap by their current earnings.
What is RJH-R's PE Ratio?
PE Ratio	12.4x
Earnings	฿546.94m
Market Cap	฿6.77b

RJH-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3x
Enterprise Value/EBITDA	10.2x
PEG Ratio	19.3x

Price to Earnings Ratio vs Peers

How does RJH-R's PE Ratio compare to its peers?

The above table shows the PE ratio for RJH-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.7x
VIH Srivichaivejvivat	16.9x	3.6%	฿5.8b
TNH Thai Nakarin Hospital	15.1x	n/a	฿6.6b
CMR Chiang Mai Ram Medical Business	26.5x	n/a	฿7.2b
PHG Patrangsit Healthcare Group	16.1x	11.6%	฿4.7b
RJH-R Rajthanee Hospital	12.4x	0.6%	฿6.8b

Price-To-Earnings vs Peers: RJH-R is good value based on its Price-To-Earnings Ratio (12.4x) compared to the peer average (18.7x).

Price to Earnings Ratio vs Industry

How does RJH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: RJH-R is good value based on its Price-To-Earnings Ratio (12.4x) compared to the TH Healthcare industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is RJH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RJH-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	12.4x
Fair PE Ratio	15.9x

Price-To-Earnings vs Fair Ratio: RJH-R is good value based on its Price-To-Earnings Ratio (12.4x) compared to the estimated Fair Price-To-Earnings Ratio (15.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Master Style

฿12.7b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿42.25

-8.2%

-7.1%

Safe Fertility Group

฿3.6b

Provides fertility medical center services in Thailand.

SAFE

฿12.00

-0.8%

-33.0%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.28

3.7%

12.0%